Alexandria Real Estate Equities (ARE) Looks Fairly Valued, Is The DCF Upside More Convincing?

Alexandria Real Estate Equities (ARE) has drawn fresh attention after recent price moves left the stock trading around $51.57, with returns mixed over the past month and past 3 months for this life science focused REIT.

Over the past year, Alexandria Real Estate Equities has seen its share price slip in the short term, with a 7 day share price return down 3.59% and a 30 day share price return down 4.09%. The 1 year total shareholder return is down 33.63%, pointing to fading momentum despite a modest 90 day share price return of 3.80% and a year to date share price gain of 5.31% from the current US$51.57 level.

Compare Alexandria Real Estate Equities’ recent pullback with other real estate and income focused candidates by scanning our handpicked 12 dividend fortresses.

Alexandria Real Estate Equities has built its reputation on life science campuses in major research hubs, yet the share price has retreated sharply over the past year. Does the current US$51.57 level fairly reflect that foundation, or does it misprice it?

Most Popular Narrative: 1.1% Overvalued

The most followed narrative places Alexandria Real Estate Equities’ fair value at about $51 per share, which is very close to the recent $51.57 price. That tight gap puts the focus on the assumptions that sit underneath that fair value rather than on any big pricing disconnect.

The analysts have a consensus price target of $51.0 for Alexandria Real Estate Equities based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $60.0, and the most bearish reporting a price target of just $42.0.

Read the complete narrative. Read the complete narrative.

Want to see what is driving that tight valuation band around Alexandria Real Estate Equities? The narrative leans heavily on a profit turnaround, margin rebuild, and a future earnings multiple that assumes investors still pay up for quality life science assets. Curious which specific growth and profitability paths need to play out to keep that $51 fair value intact.

Result: Fair Value of $51 (OVERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, for Alexandria Real Estate Equities, that fair value story could be challenged if sluggish leasing persists or if higher interest costs keep pressuring NOI and asset values.

Find out about the key risks to this Alexandria Real Estate Equities narrative.

Another View on Alexandria Real Estate Equities’ Valuation

The analyst narrative frames Alexandria Real Estate Equities as about 1.1% overvalued at around $51 per share. Yet Simply Wall St’s DCF model points the other way. It places fair value nearer $62.63, which is roughly 17.7% above the current $51.57 price. Which signal do you trust more right now?

Look into how the SWS DCF model arrives at its fair value.

Next Steps

With mixed signals on Alexandria Real Estate Equities, it makes sense to check the full picture yourself and move quickly if your view differs. To weigh up both the concerns and the potential upsides in one place, review the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Alexandria Real Estate Equities?

If Alexandria Real Estate Equities has sharpened your focus on valuation, do not stop here. Broader idea hunting can reveal opportunities that better fit your goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com